Sale!

DCDC2 Gene Nephronophthisis Type 19 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “DCDC2 Gene Nephronophthisis Type 19 Genetic Test” is a specialized diagnostic examination designed to identify mutations in the DCDC2 gene, which is associated with Nephronophthisis Type 19, a rare genetic disorder. This condition is part of a group of ciliopathies known for affecting the kidneys, leading to a progressive loss of kidney function, and potentially resulting in kidney failure. Symptoms can vary but often include polyuria, polydipsia, and secondary enuresis, reflecting the impaired concentrating ability of the kidneys.

The test is crucial for early detection, enabling healthcare providers to devise an appropriate management plan for affected individuals. It involves analyzing the patient’s DNA to look for specific genetic alterations in the DCDC2 gene that are known to cause the disorder. Early diagnosis through this test can significantly impact the treatment and management of the condition, potentially improving the quality of life for those affected.

This genetic test is available at DNA Labs UAE, a leading facility specializing in a wide array of genetic analyses. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the DCDC2 gene. By opting for this test at DNA Labs UAE, patients can expect reliable results, contributing to better-informed decisions regarding their health and management of Nephronophthisis Type 19.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

DCDC2 Gene Nephronophthisis Type 19 Genetic Test

Test Name: DCDC2 Gene Nephronophthisis Type 19 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Hepatology Nephrology Endocrinology Disorders

Doctor: General Physician

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for DCDC2 Gene Nephronophthisis Type 19 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with DCDC2 Gene Nephronophthisis Type 19 NGS Genetic DNA Test gene DCDC2

Test Details

The DCDC2 gene is associated with a rare genetic disorder called Nephronophthisis type 19 (NPHP19). Nephronophthisis is a progressive kidney disease that affects the function of the kidneys and can lead to end-stage renal disease.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of NPHP19, NGS genetic testing can be used to identify mutations or variations in the DCDC2 gene that may be responsible for the development of the disorder.

NGS genetic testing can provide valuable information for diagnosis, prognosis, and treatment decisions. It can help identify individuals who are at risk of developing NPHP19, provide genetic counseling for affected individuals and their families, and guide the development of targeted therapies.

It is important to note that NGS genetic testing for NPHP19 or any other genetic disorder should be performed and interpreted by qualified healthcare professionals who specialize in genetics. The results of genetic testing should be carefully considered in the context of an individual’s clinical symptoms, family history, and other relevant factors.

Test Name DCDC2 Gene Nephronophthisis type 19 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Hepatology Nephrology Endocrinology Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for DCDC2 Gene Nephronophthisis type 19 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with DCDC2 Gene Nephronophthisis type 19 NGS Genetic DNA Test gene DCDC2
Test Details

The DCDC2 gene is associated with a rare genetic disorder called Nephronophthisis type 19 (NPHP19). Nephronophthisis is a progressive kidney disease that affects the function of the kidneys and can lead to end-stage renal disease.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of NPHP19, NGS genetic testing can be used to identify mutations or variations in the DCDC2 gene that may be responsible for the development of the disorder.

NGS genetic testing can provide valuable information for diagnosis, prognosis, and treatment decisions. It can help identify individuals who are at risk of developing NPHP19, provide genetic counseling for affected individuals and their families, and guide the development of targeted therapies.

It is important to note that NGS genetic testing for NPHP19 or any other genetic disorder should be performed and interpreted by qualified healthcare professionals who specialize in genetics. The results of genetic testing should be carefully considered in the context of an individual’s clinical symptoms, family history, and other relevant factors.